Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,754,787 papers from all fields of science
Search
Sign In
Create Free Account
ICI 207968
Known as:
ICI-207968
, ICI207968
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Tumour necrosis factor production in a rat airpouch model of inflammation: Role of eicosanoids
M. Ferrándiz
,
S. J. Foster
Agents and Actions
2005
Corpus ID: 11220522
TNF is a potent cytokine which can induce many of the pathological changes associated with inflammatory disease.In vitro studies…
Expand
1994
1994
Potential role for interleukin-1 in the pathophysiology of ulcerative colitis.
T. Wardle
,
L. Turnberg
Clinical science
1994
Corpus ID: 38004651
1. Biopsies of colonic mucosa from patients with ulcerative colitis liberated more interleukin-1 beta, prostaglandin E2…
Expand
Highly Cited
1993
Highly Cited
1993
Inter-relationships between inflammatory mediators released from colonic mucosa in ulcerative colitis and their effects on colonic secretion.
T. Wardle
,
L. Hall
,
L. Turnberg
Gut
1993
Corpus ID: 26986991
Metabolites of arachidonic acid have been implicated in the pathophysiology of ulcerative colitis-they can stimulate intestinal…
Expand
1990
1990
2‐Substituted indazolinones: orally active and selective 5‐lipoxygenase inhibitors with anti‐inflammatory activity
S. J. Foster
,
P. Bruneau
,
E. Walker
,
R. McMillan
British journal of pharmacology
1990
Corpus ID: 45310489
1 This paper describes the pharmacological profile of ICI207968, a novel, orally‐active and selective inhibitor of 5‐lipoxygenase…
Expand
1990
1990
Leukotrienes do not regulate interleukin 1 production by activated macrophages.
B. A. Parkar
,
M. McCormick
,
S. J. Foster
Biochemical and biophysical research…
1990
Corpus ID: 921873
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE